Ann: Phase III Clinical Trial Investor Webinar, page-51

FrankieAlfie- Just for you I will try to find source later
Bonus narrative – medical cannabis
"When asked about the most exciting investment narratives or sub-sectors within the biotech sphere, Chapman again pointed to the four ASX stocks listed above.“I think all of the four companies mentioned are super exciting but not only from an investment perspective, they are exciting from a humanitarian perspective and this is what I really like about being involved in the space and hopefully making a difference to the outcomes of peoples lives.”He also gave a bonus nod, however, to medical cannabis as a grouping that he thinks could – at last – make a move higher, too.“Medical cannabis has been the worst-performing sector of the last three years, so it’s due some time in the sun soon. With positive changes coming in the US and Europe, it’s shaping up as one to watch, too.”
Kens